Could you please send me a copy of the complete article?
Also, this finding of transportation barriers faced by vulnerable
populations particularly those with physical disabilities is not new. That
is a widely known fact in the field of healthcare service systems.
*Bernadette E. Phelan, Ph.D.*
*Sr. Research Project Manager*
Arizona Department of Transportation
Research Center, MB 310B, Rm 198
206 S. 17th Avenue, Phoenix, AZ 85007
602-712-3138
bphelan(a)azdot.gov
On Wed, Apr 6, 2022 at 4:10 AM Mindell, Jenny <j.mindell(a)ucl.ac.uk> wrote:
Thanks. I couldn’t access the paper. Did they adjust
for SEP or health
behaviours? E.g. people with cancer are more likely to be smokers with a
poor diet and are more likely to be from disadvantaged communities, so it’s
presumably confounding and transport barriers are due to poor provision and
poverty not to the cancer.
Jenny
*From:* Berrigan, David (NIH/NCI) [E] <berrigad(a)mail.nih.gov>
*Sent:* 01 April 2022 13:53
*To:* trbhealth(a)mailman.chrispy.net
*Subject:* [TRBHealth] ASCO Post: US Cancer Survivors More Likely To
Report Delays In Healthcare Due To Transportation Barriers Than Individuals
Without History Of Cancer, Study Finds
Let me know if you want a copy of the complete article
US Cancer Survivors More Likely To Report Delays In Healthcare Due To
Transportation Barriers Than Individuals Without History Of Cancer, Study
Finds.
The ASCO Post
<https://mailview.bulletinintelligence.com/mailview.aspx?m=2022040101nci&r=231071-5751&l=00d-f9f&t=c>
(3/31, Stenger) reports, “In a study,” investigators “found that U.S.
cancer survivors were more likely to report delays in health care due to
transportation barriers than persons without a history of cancer, with the
difference driven by barriers among younger cancer survivors.” The
findings
<https://mailview.bulletinintelligence.com/mailview.aspx?m=2022040101nci&r=231071-5751&l=00e-bce&t=c>
were published in a research letter in JAMA Oncology.
Self-reported Transportation Barriers to Health Care Among US Cancer
Survivors. <https://pubmed.ncbi.nlm.nih.gov/35323841/>
*Jiang C*, Yabroff KR, Deng L, Wang Q, Perimbeti S, Shapiro CL, Han X.JAMA
Oncol. 2022 Mar 24. doi: 10.1001/jamaoncol.2022.0143.
David Berrigan PhD MPH
Behavioral Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
9609 Medical Center Drive MSC 7344
Room 3E342
Bethesda MD 20892-7344
Cell: 240-660-0171
Phone: 240-276-6752
Fax: 240-276-7906
berrigad(a)mail.nih.gov
You received this because you are subscribed to the mailing list
maintained by the TRB Health committee (AME70). To unsubscribe, learn more
about the list or visit the archives see
https://mailman.chrispy.net/postorius/lists/trbhealth.mailman.chrispy.net/
To connect with committee visit:
https://trbhealth.org